Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2024-05-16 2024-04-29
Drug Identification Number 02220296 02220296
Brand name PENICILLIN G SODIUM FOR INJECTION, USP PENICILLIN G SODIUM FOR INJECTION, USP
Common or Proper name PENICILLIN G SODIUM FOR INJECTION, USP PENICILLIN G SODIUM FOR INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients PENICILLIN G PENICILLIN G
Strength(s) 10000000UNIT 10000000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 50 mL 50 mL
ATC code J01CE J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-05-15 2024-05-15
Actual start date
Estimated end date 2024-06-15 2024-06-15
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL effective May 15, 2024, until June 15, 2024 Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL effective May 15, 2024, until June 15, 2024
Health Canada comments